Myeloablative Autologous Stem-Cell Transplantation for Severe SclerodermaKeith Sullivan, Daniel E. Furst, Julia Goldstein et al.|New England Journal of Medicine|2018Cited by 584
CD34 cell dose in granulocyte colony-stimulating factor–mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen–identical sibling transplantationJan Maciej Zaucha, Beverly Torok‐Storb, Theodore A. Gooley et al.|Blood|2001Cited by 227
Improved survival after acute graft- <i>versus</i> -host disease diagnosis in the modern eraH. Jean Khoury, Joseph Pidala, Tao Wang et al.|Haematologica|2017Cited by 109
High incidence of post transplant lymphoproliferative disorder after antithymocyte globulin-based conditioning and ineffective prediction by day 28 EBV-specific T lymphocyte countsMette Hoegh-Petersen, Jan Storek, Dawn Goodyear et al.|Bone Marrow Transplantation|2010Cited by 40
Preventing Measles in Immunosuppressed Cancer and Hematopoietic Cell Transplantation Patients: A Position Statement by the American Society for Transplantation and Cellular TherapySteven A. Pergam, Paul A. Carpenter, Janet A. Englund et al.|Biology of Blood and Marrow Transplantation|2019Cited by 40